Zhiyuan Zhou Selected Research

Zhiyuan Zhou Research Topics

Disease

17	Neoplasms (Cancer) 01/2024 - 01/2016
10	Lymphoma (Lymphomas) 01/2023 - 10/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2018
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2015
3	T-Cell Lymphoma (Lymphoma, T Cell) 04/2023 - 10/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
3	Sepsis (Septicemia) 06/2022 - 12/2020
3	Extranodal NK-T-Cell Lymphoma 01/2017 - 11/2014
2	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2018
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2020
2	Nasopharyngeal Carcinoma 01/2024 - 12/2022
2	Dysbiosis 01/2023 - 01/2022
2	Hypoxia (Hypoxemia) 01/2020 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 05/2018 - 01/2018
1	Wounds and Injuries (Trauma) 04/2024
1	Glioma (Gliomas) 01/2024
1	Glioblastoma (Glioblastoma Multiforme) 01/2024
1	Malignant Pleural Effusion 12/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2023
1	Colitis 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Ascites 01/2023
1	Rare Diseases (Rare Disease) 12/2022
1	Crohn Disease (Crohn's Disease) 06/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Intestinal Failure 01/2022
1	Ischemic Stroke 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Necrotizing Enterocolitis 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Ulcerative Colitis 12/2021
1	Diarrhea 06/2021
1	Neutropenia 06/2021

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 11/2014
6	Gemcitabine FDA Link 01/2022 - 11/2014
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2014
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2014
5	pegaspargase (Oncaspar)FDA Link 01/2022 - 11/2014
4	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2019
4	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 01/2018
3	Therapeutic UsesIBA 12/2023 - 01/2022
3	cytochalasin HIBA 01/2023 - 06/2018
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2019
2	Deubiquitinating EnzymesIBA 01/2024 - 01/2024
2	CytokinesIBA 12/2023 - 01/2023
2	fotemustine (Muphoran)IBA 01/2023 - 10/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2019
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2018
2	Asparaginase (Elspar)FDA Link 01/2022 - 01/2017
2	ibrutinibIBA 01/2022 - 06/2021
2	Rituximab (Mabthera)FDA Link 10/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2017
2	Prednisone (Sone)FDA LinkGeneric 01/2020 - 01/2019
2	Thalidomide (Thalomid)FDA Link 01/2020 - 01/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2019
2	LigandsIBA 10/2018 - 10/2014
2	Cytochromes c (Cytochrome c)IBA 05/2018 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2018
1	Indicators and Reagents (Reagents)IBA 04/2024
1	Annexin A5IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Large Neutral Amino Acid-Transporter 1IBA 01/2024
1	6-methyladenineIBA 01/2024
1	N-methyladenosineIBA 01/2024
1	Propidium (Propidium Iodide)IBA 01/2024
1	Sincalide FDA Link 01/2024
1	Lysine (L-Lysine)FDA Link 01/2024
1	ChemokinesIBA 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 04/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	ChitosanIBA 01/2023
1	HydrogelsIBA 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023
1	4-nitrophenyl beta-cellobiosideIBA 12/2022
1	SteroidsIBA 06/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	Erythropoietin FDA Link 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	CarcinogensIBA 12/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2021
1	Pemetrexed (MTA)FDA Link 10/2021
1	EnzymesIBA 06/2021

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2024 - 01/2015
7	Therapeutics 12/2023 - 10/2021
6	Radiotherapy 01/2024 - 01/2021
5	Immunotherapy 01/2023 - 01/2018
1	Injections 01/2023
1	Stem Cell Transplantation 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Induction Chemotherapy 10/2021